InsidersTradesSigma
Discover the full record of transactions filed by Hall Brett Matthew, Directeur Scientifique. Officer active across 1 companies, notably Immuneering Corp. Cumulatively, 6 filings have been recorded. Total volume traded: €17k. The latest transaction was disclosed on 25 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
6 of 6 declarations
Brett Matthew Hall is the Chief Scientific Officer at Immuneering Corp. In this role, he is responsible for leading scientific research and product development. Hall plays a key role in innovation and advancing the company's therapeutic solutions. His scientific expertise is essential for supporting Immuneering's mission to provide advanced treatments.